'Biosimilars market' diaporamas de présentation

Big Pharma?

1.13k views • 69 slides

Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography)

325 views • 14 slides

World Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 - 2020

Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Effective and timely formulated regulations facilitate the viability and balance between original and biosimilar products. Moreover, a favorable regulatory environment and the establishment of IPR protections are factors that boost the market growth. The upcoming patent expiration for blockbuster drugs has revolutionized the aspect of commercialization whilst triggering a large scale adoption of biosimilars. Biosimilars industry is facing problems relating to production efficiency and quantity. Get More Information @https://www.alliedmarketresearch.com/global-biosimilars-market

299 views • 12 slides

Global Biosimilars/Follow-on-Biologics Market 2013-2020

475 views • 11 slides

Biosimilar Market Forecast by 2020 (/Follow-on-Biologics)

Biosimilar Market (Follow-on-Biologics) Size, Share, Analysis, Trends, Growth, Demand, and Research Report 2014-2020 @ Big Market Research | Global Biosimilars/follow-on-biologics Market to generate an approximate revenue of $26,551.3 million by 2020, registering a CAGR of 49.1% from 2015 to 2020. Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Read Full Report @ http://www.bigmarketresearch.com/global-biosimilars-market

713 views • 11 slides

Biosimilars Market worth $6.22 Billion by 2020

The report segments the market on the basis of product, application, and region. Among various product types, the recombinant nonglycosylated protein segment is expected to account for the largest share of the market in 2015. However, the recombinant glycosylated protein segment is expected to grow at the highest CAGR during the forecast period.

188 views • 10 slides

Biosimilars Market worth $6.22 Billion by 2020

The report segments the market on the basis of product, application, and region. Among various product types, the recombinant nonglycosylated protein segment is expected to account for the largest share of the market in 2015.

176 views • 10 slides

Biosimilars Market is Anticipated To Reach $41.7 Billion By 2024

The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024. The most significant factor leading to the growth of this industry is the fact that major biological drugs are nearing the patent cliff.

115 views • 9 slides

Global Biosimilars/Follow-on-Biologics Market Size, Share

294 views • 8 slides

BIOSIMILARS- Regulatory Framework and Pipeline Analysis provides market dynamics, key players, therapy area, development phase, legal strategies, action mechanism, late stage products, competition prediction, indications, healthcare expenditure, trends, growth drivers, barriers, scope and a lot more.

265 views • 8 slides

Biosimilars Market - Global Industry Analysis and Forecast t

Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material and their manufacturing process. Generic drugs are composed of small molecules. However, biosimilars are composed of more complex molecules, such as human insulin and monoclonal antibodies. Many biosimilars are derived from plants, animals, bacteria, viruses and yeast. It is produced by recombinant DNA technology and controlled gene expression methods. Biosimilar drugs are used in prevention and treatment of various severe diseases such as cancer, diabetes, autoimmune diseases, heart attacks, rheumatoid arthritis, oncology, growth hormone deficiency, chronic kidney failure, hematological disease and infectious disease. Biosimilars offer less costly treatment than other biological drugs and synthetic drugs.

254 views • 7 slides

Key Analysis Of Biosimilars Development Market

197 views • 7 slides

Global Oncology Biosimilars Market 2015 Industry Growth, Trends, Analysis, Research and Development

Gathering and collating accurate data about the global Oncology Biosimilars market Research 2015 can be a hard task for companies operating in the market, due to the large volume of data about the market. Sifting through the wide-ranging information can be a tough task, which is where this market research report comes into the picture. Prepared by expert analysts with years of experience and spot-on market judgment, the report is a must-have accessory for all participants in the Oncology Biosimilars market.

162 views • 6 slides

Global Biosimilars Market Report

Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. Visit Us : https://www.scalarmarketresearch.com/market-reports/biosimilars-market

168 views • 6 slides

Global Biosimilars industry size is expected to increase significantly by 2024

The global biosimilars market size was valued at 3.39 billion in 2016 and is expected to grow on account of increasing prevalence of chronic diseases such as cancer and autoimmune disorders.

68 views • 6 slides

Biosimilars Market Research Report - Global Industry Analysis

Biosimilars Industry is Expected to Grow on Account of Increasing Prevalence of Chronic Diseases

73 views • 6 slides

Global Biosimilars Market Is Expected To Reach US$ 25.83 Bn By 2025

The Biosimilars  market was valued at US$ 3.52 Bn in 2016, and is expected to reach US$ 25.83 Bn by 2025, expanding at a CAGR of  23.1% from 2017 to 2025.

45 views • 4 slides

The global biosimilars market is expected to reach $6.22 Billion by 2020

Biosimilars Market categories the Global Market by Application (Oncology, Blood Disorders), Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & by Geograph

163 views • 3 slides

Biosimilars Market Product Type, Application and Specification Forecast to 2016-2021

Biosimilars Market Includes in-depth analysis of Market Application, Size, Specification, Trends, Major Manufacturers and Business Strategies by Considering Types, Market Segmentation and Analysis.

52 views • 3 slides

biosimilars market

biosimilars market

111 views • 2 slides